LP443354-8
Cabozantinib
Active
Description
Cabozantinib is an antineoplastic medication used to treat several types of cancer. In its capsule form, it is effective for metastatic medullary thyroid cancer. The tablet form is used for advanced kidney cancer, either alone or in combination with nivolumab as a first-line treatment. Additionally, cabozantinib is indicated for previously treated hepatocellular carcinoma (liver cancer) and for metastatic differentiated thyroid cancer in patients who are unable to receive radioactive iodine and have not responded well to prior treatments. This medication works by interfering with the growth of cancer cells, leading to their eventual destruction by the body. Source: LOINC
Basic Part Properties
- Part Name
- Cabozantinib
- Part Display Name
- Cabozantinib
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2024-08-22
- Construct for LOINC Short Name
- Cabozantinib
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| fr-FR | French (France) | Cabozantinib |
| it-IT | Italian (Italy) | Cabozantinib |
| pl-PL | Polish (Poland) | Kabozantynib |
| zh-CN | Chinese (China) | 卡博替尼 Synonyms: XL184 |
LOINC Copyright
Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://